Marshall Wace North America’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $55.4M | Buy |
505,691
+487,118
| +2,623% | +$53.4M | 0.24% | 88 |
|
|
2021
Q2 | $1.74M | Sell |
18,573
-211,437
| -92% | -$19.8M | 0.01% | 825 |
|
|
2021
Q1 | $21.2M | Sell |
230,010
-447,005
| -66% | -$41.1M | 0.09% | 247 |
|
|
2020
Q4 | $49.5M | Buy |
677,015
+25,709
| +4% | +$1.88M | 0.22% | 118 |
|
|
2020
Q3 | $50.6M | Sell |
651,306
-465,441
| -42% | -$36.2M | 0.32% | 73 |
|
|
2020
Q2 | $62.1M | Buy |
1,116,747
+230,653
| +26% | +$12.8M | 0.41% | 58 |
|
|
2020
Q1 | $26.2M | Buy |
886,094
+593,869
| +203% | +$17.6M | 0.2% | 136 |
|
|
2019
Q4 | $10.6M | Buy |
292,225
+34,526
| +13% | +$1.25M | 0.05% | 277 |
|
|
2019
Q3 | $7.02M | Buy |
257,699
+87,277
| +51% | +$2.38M | 0.04% | 303 |
|
|
2019
Q2 | $4.1M | Sell |
170,422
-147,432
| -46% | -$3.55M | 0.03% | 405 |
|
|
2019
Q1 | $8.4M | Buy |
317,854
+202,785
| +176% | +$5.36M | 0.06% | 230 |
|
|
2018
Q4 | $2.25M | Buy |
+115,069
| New | +$2.25M | 0.02% | 406 |
|
|
2018
Q2 | – | Sell |
-189,843
| Closed | -$2.7M | – | 1882 |
|
|
2018
Q1 | $2.7M | Sell |
189,843
-940,011
| -83% | -$13.3M | 0.01% | 731 |
|
|
2017
Q4 | $16.5M | Buy |
+1,129,854
| New | +$16.5M | 0.09% | 263 |
|